CancerConsultants provides summaries of new treatment strategies as they are discovered and reported by cancer physicians around the world. Our medical staff attends medical meetings worldwide and reviews medical literature daily to ensure appropriate news is provided to cancer patients and their families in a timely manner.
News of the results of recent clinical trials evaluating cancer therapies and supportive care strategies serve to educate patients regarding new treatment strategies for cancer and facilitate discussions with their doctor. Development of new cancer treatments usually begins in patients with recurrent or metastatic cancers. Once the new treatment appears effective, it is applied to earlier stages of the disease or to patients at higher risk of treatment failure.
Novel Immunotherapy Trial for Lymphoma Offers Hope to Patients at Sylvester (May 27, 2016)
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are testing a novel cellular immunotherapy approach to treating patients with diffuse large B-cell... Continue Reading
A new study published in the Journal of the American Medical Association (JAMA), has reported a new prevention treatment for individuals at high risk of developing colon cancer due to the APC (adenomatous... Continue Reading
CancerConnect Presents: Ask the Expert with Dana-Farber Cancer Institute’s Dr. Perez Lynch Syndrome: Get the Facts about this Hereditary Cancer Syndrome Kimberly Perez, MD CancerConnect announces the... Continue Reading
Results from a recent large trial indicate that treatment with the immunotherapy agent Opdivo® (nivolumab) nearly doubles the survival rate at one year in patients with advanced head and neck squamous... Continue Reading
Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the healthcare system Counsyl, a DNA testing... Continue Reading
News Conference Will Be Live Streamed RIGHT HERE at: 11 AM EDT; 10 AM CDT To Register Your Attendance: CLICK HERE In advance of the Institute for Clinical and Economic Research’s (ICER) plan to debate... Continue Reading
The United States Food and Drug Administration (FDA) has approved Lenvima® (lenvatinib) for the treatment of kidney cancer. The approval is for patients with advanced renal cell carcinoma who have received... Continue Reading
By Barrie Cassileth, MS, PhD Hot flashes are a common side effect of treatment in people with hormone-dependent cancers, such as breast and prostate cancer. Hormone replacement therapy, which may be used... Continue Reading
The United States Food and Drug Administration (FDA) has granted “breakthrough status” designation for the treatment of glioblastoma containing a genetically modified poliovirus. Glioblastoma is an... Continue Reading
Tess Ward, author of The Naked Cookbook answers questions and describes her approach to clean, healthy eating. Q: Can you describe a bit of your culinary training? What influences led you to offer up... Continue Reading